NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, England, UK
Radcliffe Department of Medicine, Medical Sciences Division, University of Oxford, Oxford, England, UK.
BMJ Open. 2021 Mar 23;11(3):e037935. doi: 10.1136/bmjopen-2020-037935.
OBJECTIVE: Scientific authorship is a vital marker of achievement in academic careers and gender equity is a key performance metric in research. However, there is little understanding of gender equity in publications in biomedical research centres funded by the National Institute for Health Research (NIHR). This study assesses the gender parity in scientific authorship of biomedical research. DESIGN: Descriptive, cross-sectional, retrospective bibliometric study. SETTING: NIHR Oxford Biomedical Research Centre (BRC). DATA: Data comprised 2409 publications that were either accepted or published between April 2012 and March 2017. The publications were classified as basic science studies, clinical studies (both trial and non-trial studies) and other studies (comments, editorials, systematic reviews, reviews, opinions, book chapters, meeting reports, guidelines and protocols). MAIN OUTCOME MEASURES: Gender of authors, defined as a binary variable comprising either male or female categories, in six authorship categories: first author, joint first authors, first corresponding author, joint corresponding authors, last author and joint last authors. RESULTS: Publications comprised 39% clinical research (n=939), 27% basic research (n=643) and 34% other types of research (n=827). The proportion of female authors as first author (41%), first corresponding authors (34%) and last author (23%) was statistically significantly lower than male authors in these authorship categories (p<0.001). Of total joint first authors (n=458), joint corresponding authors (n=169) and joint last authors (n=229), female only authors comprised statistically significant (p<0.001) smaller proportions, that is, 15% (n=69), 29% (n=49) and 10% (n=23) respectively, compared with male only authors in these joint authorship categories. There was a statistically significant association between gender of the last author with gender of the first author (p<0.001), first corresponding author (p<0.001) and joint last author (p<0.001). The mean journal impact factor (JIF) was statistically significantly higher when the first corresponding author was male compared with female (Mean JIF: 10.00 vs 8.77, p=0.020); however, the JIF was not statistically different when there were male and female authors as first authors and last authors. CONCLUSIONS: Although the proportion of female authors is significantly lower than the proportion of male authors in all six categories of authorship analysed, the proportions of male and female last authors are comparable to their respective proportions as principal investigators in the BRC. These findings suggest positive trends and the NIHR Oxford BRC doing very well in gender parity in the senior (last) authorship category. Male corresponding authors are more likely to publish articles in prestigious journals with high impact factor while both male and female authors at first and last authorship positions publish articles in equally prestigious journals.
目的:科研作者身份是学术生涯中成就的重要标志,性别平等是研究绩效的关键指标。然而,对于英国国家健康研究所(NIHR)资助的生物医学研究中心的出版物中的性别平等,人们知之甚少。本研究评估了生物医学研究中科研作者身份的性别均等情况。
设计:描述性、横断面、回顾性文献计量学研究。
地点:英国国家健康研究所牛津生物医学研究中心(BRC)。
数据:数据包括 2012 年 4 月至 2017 年 3 月期间接受或发表的 2409 篇出版物。这些出版物被分为基础科学研究、临床研究(试验和非试验研究)和其他研究(评论、社论、系统评价、综述、意见、章节、会议报告、指南和方案)。
主要观察指标:作者的性别,定义为包含男性或女性类别的二进制变量,在六个作者类别中:第一作者、共同第一作者、第一通讯作者、共同通讯作者、最后作者和共同最后作者。
结果:出版物中 39%为临床研究(n=939)、27%为基础研究(n=643)和 34%为其他类型的研究(n=827)。在这些作者类别中,女性作为第一作者(41%)、第一通讯作者(34%)和最后作者(23%)的比例明显低于男性作者(p<0.001)。在总共 458 位共同第一作者、169 位共同通讯作者和 229 位共同最后作者中,女性唯一作者的比例明显较小(p<0.001),分别为 15%(n=69)、29%(n=49)和 10%(n=23)。在这些共同作者类别中,与男性唯一作者相比,女性仅作者的比例较低。性别与最后作者的性别(p<0.001)、第一通讯作者(p<0.001)和共同最后作者(p<0.001)之间存在统计学显著关联。与女性第一通讯作者相比,男性第一通讯作者的期刊影响因子(JIF)平均值明显更高(平均 JIF:10.00 与 8.77,p=0.020);然而,当第一作者和最后作者有男性和女性时,JIF 没有统计学差异。
结论:尽管在分析的所有六个作者类别中,女性作者的比例明显低于男性作者,但男性和女性最后作者的比例与他们在 BRC 中的主要研究者比例相当。这些发现表明存在积极的趋势,并且英国国家健康研究所牛津 BRC 在高级(最后)作者身份类别中的性别均等方面做得非常好。男性通讯作者更有可能在具有高影响因子的知名期刊上发表文章,而第一作者和最后作者的男性和女性作者都在同等知名的期刊上发表文章。
Biol Psychiatry. 2019-2-19
Ophthalmology. 2016-5-22
Public Health Chall. 2023-3-3
J Public Health Afr. 2025-4-16
Braz Oral Res. 2024-12-9
Transl Lung Cancer Res. 2023-5-31
Br J Gen Pract. 2023-2